TKG Huchems, KR7069260008

TKG Huchems ended a KRW 293.95 billion deal: TKG Huchems stock yields 4.90 percent

Published on 10/14/2026 at 05:10 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

TKG Huchems ended a KRW 293.95 billion deal on September 29, 2026. For TKG Huchems stock, first-half revenue rose 23.70 percent to KRW 692.10 billion.

Contract changes and reporting dates

  • TKG Huchems terminated a KRW 293.95 billion DNT sales contract on September 29, 2026.
  • A KRW 337.80 billion nitric acid supply contract was signed on September 28, 2026.
  • TKG Huchems was trading at KRW 15,770 on KRX on October 14, 2026 at 11:49 a.m. KST.
  • First-half revenue rose 23.70 percent to KRW 692.10 billion in 2026.
  • The third-quarter report deadline is November 16, 2026.
TKG Huchems, KR7069260008, Illustration mit AI erstellt.
TKG Huchems, KR7069260008, Illustration mit AI erstellt.

TKG Huchems (ISIN KR7069260008) terminated a KRW 293.95 billion DNT sales contract on September 29, 2026, while TKG Huchems stock carries a reported 4.90 percent dividend yield. ATS View identifies the contract termination as the latest reported filing and records the 2025 dividend yield.

Three dated operating signals

On August 14, 2026, TKG Huchems had reported first-half revenue of KRW 692.10 billion, up 23.70 percent year over year, with operating profit of KRW 48.00 billion. ATS View also lists second-quarter revenue of KRW 397.20 billion, up 36.90 percent, and operating profit of KRW 32.80 billion.

On September 28, 2026, the company signed a KRW 337.80 billion nitric acid supply contract running from March 31, 2029, through March 30, 2039. Global Economic reported that the agreement covers 10 years and about 1.80 million tons of nitric acid.

What does the deal change?

The two September filings show both opportunity and execution risk. The supply contract equals 30.00 percent of the company's most recently reported annual revenue, according to DataTooza, but the following day's termination filing underlines that announced chemical sales do not automatically become durable revenue.

For investors, the comparison between first-half growth and the canceled DNT agreement is material. Revenue increased 23.70 percent in the first half of 2026, while the terminated contract represented KRW 293.95 billion, a separate figure from the KRW 337.80 billion nitric acid agreement.

Dates and trading context

The next dated filing milestone is November 16, 2026, the legal deadline for the third-quarter report covering July through September. ATS View lists that deadline alongside the company's recent filings.

TKG Huchems was trading at KRW 15,770 on the Korea Exchange on October 14, 2026 at 11:49 a.m. KST. The quote was 10.24 percent above the 52-week low of KRW 14,300 and 26.82 percent below the 52-week high of KRW 21,550, using the same market-data snapshot.

Market context: Market report KOSPI.

TKG Huchems stock facts

  • Company: TKG Huchems Co., Ltd.
  • ISIN: KR7069260008
  • Ticker: 069260
  • Primary exchange: Korea Exchange, KOSPI
  • Latest price on KRX: KRW 15,770 as of October 14, 2026 at 11:49 a.m. KST
  • Market capitalization: KRW 605.1 billion as of October 14, 2026
  • 52-week range: KRW 14,300.00-21,550.00 as of October 14, 2026
  • Sector / Industry: Chemicals
  • Index membership: KOSPI

More news and analyses on TKG Huchems stock

Disclaimer...

en | KR7069260008 | TKG HUCHEMS | boerse | 70319253 | bgmi